Publication Information

{'id': 'https://openalex.org/W3032354441', 'doi': 'https://doi.org/10.3760/cma.j.issn.1671-0274.2003.03.018', 'title': 'Expression and clinical significance of survivin in gastric cancer', 'display_name': 'Expression and clinical significance of survivin in gastric cancer', 'publication_year': 2003, 'publication_date': '2003-05-25', 'ids': {'openalex': 'https://openalex.org/W3032354441', 'doi': 'https://doi.org/10.3760/cma.j.issn.1671-0274.2003.03.018', 'mag': '3032354441'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'http://rs.yiigle.com/CN441530200303/728089.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306541289', 'display_name': '中华胃肠外科杂志', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5045023771', 'display_name': '孙益红', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': '孙益红', 'raw_affiliation_strings': ['200032,上海,复旦大学附属中山医院普通外科'], 'affiliations': [{'raw_affiliation_string': '200032,上海,复旦大学附属中山医院普通外科', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5057951628', 'display_name': '汪学非', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': '汪学非', 'raw_affiliation_strings': ['200032,上海,复旦大学附属中山医院病理科'], 'affiliations': [{'raw_affiliation_string': '200032,上海,复旦大学附属中山医院病理科', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5015939064', 'display_name': '秦新裕', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': '秦新裕', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5066153221', 'display_name': '王承棓', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': '王承棓', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5081720528', 'display_name': '卢韶华', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': '卢韶华', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5091574380', 'display_name': '周燕南', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': '周燕南', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.406431, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 59, 'max': 66}, 'biblio': {'volume': '6', 'issue': '3', 'first_page': '191', 'last_page': '194'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T13779', 'display_name': 'Cancer Mechanisms and Therapy', 'score': 0.9944, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T13779', 'display_name': 'Cancer Mechanisms and Therapy', 'score': 0.9944, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9941, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12996', 'display_name': 'Cancer Research and Treatments', 'score': 0.9939, 'subfield': {'id': 'https://openalex.org/subfields/1305', 'display_name': 'Biotechnology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/survivin', 'display_name': 'Survivin', 'score': 0.9980451}], 'concepts': [{'id': 'https://openalex.org/C2775975398', 'wikidata': 'https://www.wikidata.org/wiki/Q906904', 'display_name': 'Survivin', 'level': 3, 'score': 0.9980451}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.4488778}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.41772005}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.39842886}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.3322336}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.29068092}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'http://rs.yiigle.com/CN441530200303/728089.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306541289', 'display_name': '中华胃肠外科杂志', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.71, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3032558745', 'https://openalex.org/W3032438302', 'https://openalex.org/W3032415475', 'https://openalex.org/W3032337009', 'https://openalex.org/W3032169548', 'https://openalex.org/W3032154559', 'https://openalex.org/W3031838151', 'https://openalex.org/W3030897382', 'https://openalex.org/W3030833610', 'https://openalex.org/W3029778193', 'https://openalex.org/W3029685388', 'https://openalex.org/W3029566881', 'https://openalex.org/W3029530062', 'https://openalex.org/W3029489769', 'https://openalex.org/W3029180155', 'https://openalex.org/W3029131785', 'https://openalex.org/W3029064006', 'https://openalex.org/W2808201006', 'https://openalex.org/W2392262231', 'https://openalex.org/W2375742566'], 'abstract_inverted_index': {'目的探讨胃癌组织中凋亡抑制因子': [0], 'survivin的表达及其与各临床病理因素的关系,评价': [1], 'survivin在胃癌预后判断中的价值.方法应用免疫组织化学': [2], 'EnVision两步法检测': [3], '140例胃癌组织中': [4], 'survivin的表达情况,回顾性分析': [5], 'survivin与各临床病理因素及预后之间的关系.结果胃癌组织中': [6], 'survivin表达阳性率为': [7], '46.': [8], '4%(': [9], '65/140).累及浆膜层的胃癌': [10], 'survivin表达阳性率(': [11, 17, 26], '53.': [12], '2%)明显高于未及浆膜层者(': [13], '32.': [14], '6%),': [15], 'TNM分期Ⅲ、Ⅳ期的胃癌': [16], '55.': [18], '2%)明显高于Ⅰ、Ⅱ期者(': [19], '38.': [20], '4%)(': [21], 'P均': [22], '<': [23], '0.': [24, 40], '05).分化较差的胃癌': [25], '52.': [27], '2%)与分化较好者差异无显著性意义(': [28], '35.': [29], '4%': [30], ',P=0.': [31], '059).': [32], 'survivin表达阳性患者': [33], '5年生存率(': [34], '34.': [35], '4%)明显低于表达阴性者(': [36], '58.': [37], '6%,': [38], 'P<': [39], '006).': [41], 'Cox回归模型分析显示,': [42], 'survivin表达状态是胃癌根治术后独立的预后因素,阳性表达提示预后不良.结论凋亡抑制因子': [43], 'survivin在胃癌组织中具有较高的表达率,其表达与胃癌的浸润深度和': [44], 'TNM分期相关.': [45], 'survivin的表达状态是胃癌根治术后独立的预后因素,阳性表达提示预后不良.': [46]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3032354441', 'counts_by_year': [{'year': 2013, 'cited_by_count': 1}], 'updated_date': '2024-12-13T01:03:50.772660', 'created_date': '2020-06-05'}